2880:TWSEHua Nan Financial Holdings Co., Ltd. Analysis
Data as of 2026-07-11 - not real-time
NT$38.85
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Hua Nan Financial is trading above its 20‑day, 50‑day and 200‑day moving averages, with a bullish MACD crossover and an RSI comfortably in the 60s, indicating momentum is still intact. Price action sits just below the recent resistance around 39.9 TWD and above the identified support at 35.75 TWD, suggesting limited upside in the near term. Fundamentally, revenue has surged over 25% year‑over‑year, yet operating cash flow is sharply negative and the balance sheet carries a massive debt load that offsets its cash reserves, raising questions about dividend sustainability despite a 3.2% yield. The stock’s beta is exceptionally low, but 30‑day volatility exceeds 50%, and the market is currently in an "Extreme Greed" sentiment phase, which could amplify price swings. Overall, the blend of strong earnings momentum, elevated valuation multiples versus industry peers, and cash‑flow weakness points to a cautious stance: hold the current position while monitoring cash‑flow trends and any catalyst that could unlock the high‑yield dividend.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with bullish MACD but decreasing volume
- RSI in moderate range, no overbought signal
- High short‑term market sentiment (Extreme Greed) could prompt volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue growth of ~25% but operating cash flow remains negative
- Valuation multiples above industry average (PE ~20 vs 17.6)
- Debt levels high relative to cash flow, limiting upside potential
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Dividend yield attractive but sustainability questionable due to cash‑flow strain
- Low beta suggests defensive profile, yet volatility is elevated
- Potential for strategic restructuring or asset sales to improve balance‑sheet health
Key Metrics & Analysis
Financial Health
Revenue Growth25.30%
Profit Margin40.25%
P/E Ratio20.4
ROE12.25%
ROA0.68%
P/B Ratio2.2
Op. Cash FlowNT$-187957526528
Industry P/E17.6
Technical Analysis
TrendBullish
RSI60.4
SupportNT$35.75
ResistanceNT$39.90
MA 20NT$37.72
MA 50NT$34.81
MA 200NT$32.63
MACDBullish
VolumeDecreasing
Fear & Greed Index94.59
Valuation
Target PriceNT$30.30
Upside/Downside-22.01%
GradeOvervalued
TypeBlend
Dividend Yield3.22%
Risk Assessment
Beta0.11
Volatility50.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.